vTv Therapeutics Inc. (VTVT) Earnings Signals & AI Vibe Check

Latest Filing: 10-Q  |  Filed May 13, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for vTv Therapeutics Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-Q, vTv Therapeutics Inc.'s filing signal continuing positive.
earningsVibe SuperAnalyst™ Verdict: CONTINUING POSITIVE

Signal Performance — Stock Price Since Filing

30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Turned Positive
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Turned Positive

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does vTv Therapeutics Inc. actually do?
Answer:
vTv Therapeutics Inc. is a late-stage biopharmaceutical company focused on developing orally administered therapies for metabolic and inflammatory diseases. Its lead product candidate, cadisegliatin (TTP399), is a small-molecule, liver-selective glucokinase activator being evaluated as an adjunctive therapy to insulin for type 1 diabetes (T1D). Cadisegliatin has received FDA Breakthrough Therapy designation, supported by Phase 2 trial results showing a reduction in hypoglycemia and improvement in HbA1c. The company is also advancing other pipeline candidates through collaborations and has a Phase 2 trial for type 2 diabetes in the Middle East. vTv Therapeutics aims to address the significant unmet medical need for a safe oral treatment option in diabetes management.
Question:
What are vTv Therapeutics Inc.'s revenue drivers?
Answer:
Revenue is primarily derived from milestone payments, upfront proceeds, and research fees under collaboration and license agreements. Future revenue may include product sales, license fees, milestone payments, and royalties.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required